可視化

発行年ごと論文数

著者正規化top50

著者正規化top50の共著関係

タイトル語top50

タイトル語top50の共起

ジャーナル一覧

ジャーナル分野比率


論文リスト

doi title author source_title year
190 10.1001/jamaoncol.2017.2925 Association Of Immune-Related Adverse Events With Nivolumab Efficacy In Non<U+2013>Small-Cell Lung Cancer Haratani, Koji; Hayashi, Hidetoshi; Chiba, Yasutaka; Kudo, Keita; Yonesaka, Kimio; Kato, Ryoji; Kaneda, Hiroyasu; Hasegawa, Yoshikazu; Tanaka, Kaoru; Takeda, Masayuki; Nakagawa, Kazuhiko Jama Oncology 2018
200 10.1001/jamaoncol.2018.4514 Survival Outcomes In Patients With Previously Untreated Braf Wild-Type Advanced Melanoma Treated With Nivolumab Therapy Ascierto, Paolo A.; Long, Georgina V.; Robert, Caroline; Brady, Benjamin; Dutriaux, Caroline; Di Giacomo, Anna Maria; Mortier, Laurent; Hassel, Jessica C.; Rutkowski, Piotr; Mcneil, Catriona; Kalinka-Warzocha, Ewa; Savage, Kerry J.; Hernberg, Micaela M.; Lebbe, Celeste; Charles, Julie; Mihalcioiu, Catalin; Chiarion-Sileni, Vanna; Mauch, Cornelia; Cognetti, Francesco; Ny, Lars; Arance, Ana; Svane, Inge Marie; Schadendorf, Dirk; Gogas, Helen; Saci, Abdel; Jiang, Joel; Rizzo, Jasmine; Atkinson, Victoria Jama Oncology 2019
205 10.1001/jamaoncol.2018.5860 Profiling Preexisting Antibodies In Patients Treated With Anti<U+2013>Pd-1 Therapy For Advanced Non<U+2013>Small Cell Lung Cancer Toi, Yukihiro; Sugawara, Shunichi; Sugisaka, Jun; Ono, Hirotaka; Kawashima, Yosuke; Aiba, Tomoiki; Kawana, Sachiko; Saito, Ryohei; Aso, Mari; Tsurumi, Kyoji; Suzuki, Kana; Shimizu, Hisashi; Domeki, Yutaka; Terayama, Keisuke; Nakamura, Atsushi; Yamanda, Shinsuke; Kimura, Yuichiro; Honda, Yoshihiro Jama Oncology 2019
211 10.1001/jamaoncol.2019.0402 Association Of Checkpoint Inhibitor<U+2013>Induced Toxic Effects With Shared Cancer And Tissue Antigens In Non<U+2013>Small Cell Lung Cancer Berner, Fiamma; Bomze, David; Diem, Stefan; Ali, Omar Hasan; Fassler, Mirjam; Ring, Sandra; Niederer, Rebekka; Ackermann, Christoph J.; Baumgaertner, Petra; Pikor, Natalia; Cruz, Cristina Gil; Van De Veen, Willem; Akdis, Mubeccel; Nikolaev, Sergey; Laubli, Heinz; Zippelius, Alfred; Hartmann, Fabienne; Cheng, Hung-Wei; Honger, Gideon; Recher, Mike; Goldman, Jonathan; Cozzio, Antonio; Fruh, Martin; Neefjes, Jacques; Driessen, Christoph; Ludewig, Burkhard; Hegazy, Ahmed N.; Jochum, Wolfram; Speiser, Daniel E.; Flatz, Lukas Jama Oncology 2019
219 10.1001/jamaoncol.2019.5570 Association Between Immune-Related Adverse Events And Recurrence-Free Survival Among Patients With Stage Iii Melanoma Randomized To Receive Pembrolizumab Or Placebo Eggermont, Alexander M. M.; Kicinski, Michal; Blank, Christian U.; Mandala, Mario; Long, Georgina V.; Atkinson, Victoria; Dalle, Stephane; Haydon, Andrew; Khattak, Adnan; Carlino, Matteo S.; Sandhu, Shahneen; Larkin, James; Puig, Susana; Ascierto, Paolo A.; Rutkowski, Piotr; Schadendorf, Dirk; Koornstra, Rutger; Hernandez-Aya, Leonel; Di Giacomo, Anna Maria; Van Den Eertwegh, Alfonsus J. M.; Grob, Jean-Jacques; Gutzmer, Ralf; Jamal, Rahima; Lorigan, Paul C.; Krepler, Clemens; Ibrahim, Nageatte; Marreaud, Sandrine; Van Akkooi, Alexander; Robert, Caroline; Suciu, Stefan Jama Oncology 2020
2525 10.1007/s00432-018-2805-3 Impact Of Immune-Related Adverse Events On Survival In Patients With Advanced Non-Small Cell Lung Cancer Treated With Nivolumab: Long-Term Outcomes From A Multi-Institutional Analysis Ricciuti, Biagio, 0000-0002-0651-2678; Genova, Carlo; De Giglio, Andrea; Bassanelli, Maria; Dal Bello, Maria Giovanna; Metro, Giulio; Brambilla, Marta; Baglivo, Sara; Grossi, Francesco; Chiari, Rita Journal Of Cancer Research And Clinical Oncology 2018
2526 10.1007/s00432-018-2819-x Immune-Related Adverse Events Correlate With Improved Survival In Patients Undergoing Anti-Pd1 Immunotherapy For Metastatic Melanoma Indini, Alice, 0000-0001-8686-4106; Di Guardo, Lorenza; Cimminiello, Carolina; Prisciandaro, Michele; Randon, Giovanni; De Braud, Filippo; Del Vecchio, Michele Journal Of Cancer Research And Clinical Oncology 2018
4889 10.1016/j.clinthera.2018.11.004 Association Between Immune-Related Adverse Events And Clinical Efficacy In Patients With Melanoma Treated With Nivolumab: A Multicenter Retrospective Study Okada, Naoto; Kawazoe, Hitoshi, 0000-0003-1591-4051; Takechi, Kenshi; Matsudate, Yoshihiro; Utsunomiya, Ryo; Zamami, Yoshito, 0000-0002-7879-423X; Goda, Mitsuhiro; Imanishi, Masaki; Chuma, Masayuki; Hidaka, Noriaki; Sayama, Koji; Kubo, Yoshiaki; Tanaka, Akihiro; Ishizawa, Keisuke Clinical Therapeutics 2019
4890 10.1016/j.cllc.2018.10.002 Association Between Immune-Related Adverse Events And Efficacy Of Immune Checkpoint Inhibitors In Non<U+2013>Small-Cell Lung Cancer Grangeon, Mathieu; Tomasini, Pascale; Chaleat, Solene; Jeanson, Arnaud; Souquet-Bressand, Maxime; Khobta, Nataliya; Bermudez, Julien; Trigui, Youssef; Greillier, Laurent; Blanchon, Marilyne; Boucekine, Mohamed; Mascaux, Celine; Barlesi, Fabrice Clinical Lung Cancer 2019
4891 10.1016/j.cllc.2019.02.006 Correlations Between The Immune-Related Adverse Events Spectrum And Efficacy Of Anti-Pd1 Immunotherapy In Nsclc Patients Cortellini, Alessio, 0000-0002-1209-5735; Chiari, Rita; Ricciuti, Biagio, 0000-0002-0651-2678; Metro, Giulio, 0000-0002-4978-9212; Perrone, Fabiana; Tiseo, Marcello; Bersanelli, Melissa; Bordi, Paola; Santini, Daniele; Giusti, Raffaele, 0000-0003-4592-8868; Grassadonia, Antonino; Di Marino, Pietro; Tinari, Nicola; De Tursi, Michele; Zoratto, Federica; Veltri, Enzo; Malorgio, Francesco; Garufi, Carlo; Russano, Marco; Anesi, Cecilia; Zeppola, Tea; Filetti, Marco, 0000-0002-4734-7541; Marchetti, Paolo; Berardi, Rossana; Rinaldi, Silvia; Tudini, Marianna; Silva, Rosa Rita; Pireddu, Annagrazia; Atzori, Francesco; Iacono, Daniela; Migliorino, Maria Rita; Porzio, Giampiero; Cannita, Katia; Ficorella, Corrado; Buti, Sebastiano, 0000-0003-0876-0226 Clinical Lung Cancer 2019
5448 10.1016/j.ejca.2018.10.014 Immune-Related Adverse Events Predict The Therapeutic Efficacy Of Anti<U+2013>Pd-1 Antibodies In Cancer Patients Rogado, J.; Sanchez-Torres, J.M.; Romero-Laorden, N.; Ballesteros, A.I.; Pacheco-Barcia, V.; Ramos-Levi, A.; Arranz, R.; Lorenzo, A.; Gullon, P.; Donnay, O.; Adrados, M.; Costas, P.; Aspa, J.; Alfranca, A.; Mondejar, R.; Colomer, R., 0000-0002-6393-3444 European Journal Of Cancer 2019
5456 10.1016/j.ejca.2019.07.001 Adjuvant Ipilimumab Versus Placebo After Complete Resection Of Stage Iii Melanoma: Long-Term Follow-Up Results Of The European Organisation For Research And Treatment Of Cancer 18071 Double-Blind Phase 3 Randomised Trial Eggermont, Alexander M.M.; Chiarion-Sileni, Vanna; Grob, Jean-Jacques, 0000-0002-1014-4062; Dummer, Reinhard; Wolchok, Jedd D.; Schmidt, Henrik; Hamid, Omid; Robert, Caroline; Ascierto, Paolo Antonio, 0000-0002-8322-475X; Richards, Jon M.; Lebbe, Celeste; Ferraresi, Virginia; Smylie, Michael; Weber, Jeffrey S.; Maio, Michele; Hosein, Fareeda; De Pril, Veerle; Kicinski, Michal; Suciu, Stefan; Testori, Alessandro European Journal Of Cancer 2019
5459 10.1016/j.ejca.2019.11.016 Update On Tolerability And Overall Survival In Columbus: Landmark Analysis Of A Randomised Phase 3 Trial Of Encorafenib Plus Binimetinib Vs Vemurafenib Or Encorafenib In Patients With Braf V600<U+2013>Mutant Melanoma Ascierto, Paolo A.; Dummer, Reinhard; Gogas, Helen J.; Flaherty, Keith T.; Arance, Ana; Mandala, Mario; Liszkay, Gabriella; Garbe, Claus; Schadendorf, Dirk; Krajsova, Ivana; Gutzmer, Ralf; De Groot, Jan Willem B.; Loquai, Carmen; Gollerkeri, Ashwin; Pickard, Michael D.; Robert, Caroline European Journal Of Cancer 2020
10166 10.1016/s0140-6736(20)30417-7 Adjuvant Nivolumab Plus Ipilimumab Or Nivolumab Monotherapy Versus Placebo In Patients With Resected Stage Iv Melanoma With No Evidence Of Disease (Immuned): A Randomised, Double-Blind, Placebo-Controlled, Phase 2 Trial Zimmer, Lisa; Livingstone, Elisabeth; Hassel, Jessica C; Fluck, Michael; Eigentler, Thomas; Loquai, Carmen; Haferkamp, Sebastian; Gutzmer, Ralf; Meier, Friedegund; Mohr, Peter; Hauschild, Axel; Schilling, Bastian; Menzer, Christian; Kieker, Felix; Dippel, Edgar; Rosch, Alexander; Simon, Jan-Christoph; Conrad, Beate; Korner, Silvia; Windemuth-Kieselbach, Christine; Schwarz, Leonora; Garbe, Claus; Becker, Jurgen C; Schadendorf, Dirk; Berking, Carola; Herbst, Rudolf A; Martens, Uwe M; Sell, Sabine; Stadler, Rudolf; Terheyden, Patrick; Utikal, Jochen The Lancet 2020
10180 10.1016/s0140-6736(20)30934-x Atezolizumab, Vemurafenib, And Cobimetinib As First-Line Treatment For Unresectable Advanced Brafv600 Mutation-Positive Melanoma (Imspire150): Primary Analysis Of The Randomised, Double-Blind, Placebo-Controlled, Phase 3 Trial Gutzmer, Ralf; Stroyakovskiy, Daniil; Gogas, Helen; Robert, Caroline; Lewis, Karl; Protsenko, Svetlana; Pereira, Rodrigo P; Eigentler, Thomas; Rutkowski, Piotr; Demidov, Lev; Manikhas, Georgy Moiseevich; Yan, Yibing; Huang, Kuan-Chieh; Uyei, Anne; Mcnally, Virginia; Mcarthur, Grant A; Ascierto, Paolo A The Lancet 2020
10250 10.1016/s1470-2045(18)30142-6 Encorafenib Plus Binimetinib Versus Vemurafenib Or Encorafenib In Patients With Braf -Mutant Melanoma (Columbus): A Multicentre, Open-Label, Randomised Phase 3 Trial Dummer, Reinhard; Ascierto, Paolo A; Gogas, Helen J; Arance, Ana; Mandala, Mario; Liszkay, Gabriella; Garbe, Claus; Schadendorf, Dirk; Krajsova, Ivana; Gutzmer, Ralf; Chiarion-Sileni, Vanna; Dutriaux, Caroline; De Groot, Jan Willem B; Yamazaki, Naoya; Loquai, Carmen; Moutouh-De Parseval, Laure A; Pickard, Michael D; Sandor, Victor; Robert, Caroline; Flaherty, Keith T The Lancet Oncology 2018
10260 10.1016/s1470-2045(18)30497-2 Overall Survival In Patients With Braf-Mutant Melanoma Receiving Encorafenib Plus Binimetinib Versus Vemurafenib Or Encorafenib (Columbus): A Multicentre, Open-Label, Randomised, Phase 3 Trial Dummer, Reinhard; Ascierto, Paolo A; Gogas, Helen J; Arance, Ana; Mandala, Mario; Liszkay, Gabriella; Garbe, Claus; Schadendorf, Dirk; Krajsova, Ivana; Gutzmer, Ralf; Chiarion Sileni, Vanna; Dutriaux, Caroline; De Groot, Jan Willem B; Yamazaki, Naoya; Loquai, Carmen; Moutouh-De Parseval, Laure A; Pickard, Michael D; Sandor, Victor; Robert, Caroline; Flaherty, Keith T The Lancet Oncology 2018
10287 10.1016/s1470-2045(19)30151-2 Identification Of The Optimal Combination Dosing Schedule Of Neoadjuvant Ipilimumab Plus Nivolumab In Macroscopic Stage Iii Melanoma (Opacin-Neo): A Multicentre, Phase 2, Randomised, Controlled Trial Rozeman, Elisa A; Menzies, Alexander M; Van Akkooi, Alexander C J; Adhikari, Chandra; Bierman, Carolien; Van De Wiel, Bart A; Scolyer, Richard A; Krijgsman, Oscar; Sikorska, Karolina; Eriksson, Hanna; Broeks, Annegien; Van Thienen, Johannes V; Guminski, Alexander D; Acosta, Alex Torres; Ter Meulen, Sylvia; Koenen, Anne Miek; Bosch, Linda J W; Shannon, Kerwin; Pronk, Loes M; Gonzalez, Maria; Ch’Ng, Sydney; Grijpink-Ongering, Lindsay G; Stretch, Jonathan; Heijmink, Stijn; Van Tinteren, Harm; Haanen, John B A G; Nieweg, Omgo E; Klop, Willem M C; Zuur, Charlotte L; Saw, Robyn P M; Van Houdt, Winan J; Peeper, Daniel S; Spillane, Andrew J; Hansson, Johan; Schumacher, Ton N; Long, Georgina V; Blank, Christian U The Lancet Oncology 2019
10292 10.1016/s1470-2045(19)30331-6 Neoadjuvant Dabrafenib Combined With Trametinib For Resectable, Stage Iiib<U+2013>C, Brafv600 Mutation-Positive Melanoma (Neocombi): A Single-Arm, Open-Label, Single-Centre, Phase 2 Trial Long, Georgina V; Saw, Robyn P M; Lo, Serigne; Nieweg, Omgo E; Shannon, Kerwin F; Gonzalez, Maria; Guminski, Alexander; Lee, Jenny H; Lee, Hansol; Ferguson, Peter M; Rawson, Robert V; Wilmott, James S; Thompson, John F; Kefford, Richard F; Ch’Ng, Sydney; Stretch, Jonathan R; Emmett, Louise; Kapoor, Rony; Rizos, Helen; Spillane, Andrew J; Scolyer, Richard A; Menzies, Alexander M The Lancet Oncology 2019
10293 10.1016/s1470-2045(19)30332-8 Neoadjuvant Systemic Therapy In Melanoma: Recommendations Of The International Neoadjuvant Melanoma Consortium Amaria, Rodabe N; Menzies, Alexander M; Burton, Elizabeth M; Scolyer, Richard A; Tetzlaff, Michael T; Antdbacka, Robert; Ariyan, Charlotte; Bassett, Roland; Carter, Brett; Daud, Adil; Faries, Mark; Fecher, Leslie A; Flaherty, Keith T; Gershenwald, Jeffrey E; Hamid, Omid; Hong, Angela; Kirkwood, John M; Lo, Serigne; Margolin, Kim; Messina, Jane; Postow, Michael A; Rizos, Helen; Ross, Merrick I; Rozeman, Elisa A; Saw, Robyn P M; Sondak, Vernon; Sullivan, Ryan J; Taube, Janis M; Thompson, John F; Van De Wiel, Bart A; Eggermont, Alexander M; Davies, Michael A; Ascierto, Paolo A; Spillane, Andrew J; Van Akkooi, Alexander C J; Wargo, Jennifer A; Blank, Christian U; Tawbi, Hussein A; Long, Georgina V; Andrews, Miles C; Berry, Donald A; Block, Matthew S; Boland, Genevieve M; Bollin, Kathryn B; Carlino, Matteo S; Carvajal, Richard D; Cohen, Jonathan; Davar, Diwakar; Delman, Keith A; Dummer, Reinhard; Farwell, Michael D; Fisher, David E; Fusi, Alberto; Glitza, Isabella C; De Gruijl, Tanja D; Gyorki, David E; Hauschild, Axel; Hieken, Tina J; Larkin, James; Lawson, David H; Lebbe, Celeste; Lee, Jeffrey E; Lowe, Michael C; Luke, Jason J; Mcarthur, Grant A; Mcdermott, David F; Mcquade, Jennifer L; Mitchell, Tara C; Petrella, Teresa M; Prieto, Peter A; Puzanov, Igor; Robert, Caroline; Salama, April K; Sandhu, Shaneen; Schadendorf, Dirk; Shoushtari, Alexander N; Sosman, Jeffrey A; Swetter, Susan M; Tanabe, Ken K; Turajlic, Samra; Tyler, Douglas S; Woodman, Scott E; Wright, Frances C; Zager, Jonathan S The Lancet Oncology 2019
10296 10.1016/s1470-2045(19)30388-2 Pembrolizumab Versus Ipilimumab In Advanced Melanoma (Keynote-006): Post-Hoc 5-Year Results From An Open-Label, Multicentre, Randomised, Controlled, Phase 3 Study Robert, Caroline; Ribas, Antoni; Schachter, Jacob; Arance, Ana; Grob, Jean-Jacques; Mortier, Laurent; Daud, Adil; Carlino, Matteo S; Mcneil, Catriona M; Lotem, Michal; Larkin, James M G; Lorigan, Paul; Neyns, Bart; Blank, Christian U; Petrella, Teresa M; Hamid, Omid; Su, Shu-Chih; Krepler, Clemens; Ibrahim, Nageatte; Long, Georgina V The Lancet Oncology 2019
10347 10.1016/s1470-2045(20)30494-0 Adjuvant Nivolumab Versus Ipilimumab In Resected Stage Iiib<U+2013>C And Stage Iv Melanoma (Checkmate 238): 4-Year Results From A Multicentre, Double-Blind, Randomised, Controlled, Phase 3 Trial Ascierto, Paolo A; Del Vecchio, Michele; Mandala, Mario; Gogas, Helen; Arance, Ana M; Dalle, Stephane; Cowey, C Lance; Schenker, Michael; Grob, Jean-Jacques; Chiarion-Sileni, Vanna; Marquez-Rodas, Ivan; Butler, Marcus O; Maio, Michele; Middleton, Mark R; De La Cruz-Merino, Luis; Arenberger, Petr; Atkinson, Victoria; Hill, Andrew; Fecher, Leslie A; Millward, Michael; Khushalani, Nikhil I; Queirolo, Paola; Lobo, Maurice; De Pril, Veerle; Loffredo, John; Larkin, James; Weber, Jeffrey The Lancet Oncology 2020
14656 10.1038/s41591-018-0197-1 Neoadjuvant Immune Checkpoint Blockade In High-Risk Resectable Melanoma Amaria, Rodabe N., 0000-0001-6876-278X; Reddy, Sangeetha M.; Tawbi, Hussein A.; Davies, Michael A., 0000-0002-0977-0912; Ross, Merrick I.; Glitza, Isabella C.; Cormier, Janice N.; Lewis, Carol; Hwu, Wen-Jen; Hanna, Ehab; Diab, Adi; Wong, Michael K.; Royal, Richard; Gross, Neil, 0000-0002-9427-0743; Weber, Randal; Lai, Stephen Y.; Ehlers, Richard; Blando, Jorge; Milton, Denai R.; Woodman, Scott; Kageyama, Robin; Wells, Daniel K.; Hwu, Patrick; Patel, Sapna P.; Lucci, Anthony; Hessel, Amy; Lee, Jeffrey E.; Gershenwald, Jeffrey; Simpson, Lauren; Burton, Elizabeth M.; Posada, Liberty; Haydu, Lauren; Wang, Linghua, 0000-0001-9380-0266; Zhang, Shaojun; Lazar, Alexander J., 0000-0002-6395-4499; Hudgens, Courtney W., 0000-0001-8312-7485; Gopalakrishnan, Vancheswaran; Reuben, Alexandre, 0000-0003-4510-0382; Andrews, Miles C.; Spencer, Christine N.; Prieto, Victor; Sharma, Padmanee; Allison, James; Tetzlaff, Michael T.; Wargo, Jennifer A. Nature Medicine 2018
14657 10.1038/s41591-018-0198-0 Neoadjuvant Versus Adjuvant Ipilimumab Plus Nivolumab In Macroscopic Stage Iii Melanoma Blank, Christian U.; Rozeman, Elisa A.; Fanchi, Lorenzo F.; Sikorska, Karolina; Van De Wiel, Bart; Kvistborg, Pia; Krijgsman, Oscar; Van Den Braber, Marlous; Philips, Daisy; Broeks, Annegien; Van Thienen, Johannes V.; Mallo, Henk A.; Adriaansz, Sandra; Ter Meulen, Sylvia; Pronk, Loes M.; Grijpink-Ongering, Lindsay G.; Bruining, Annemarie; Gittelman, Rachel M.; Warren, Sarah; Van Tinteren, Harm; Peeper, Daniel S.; Haanen, John B. A. G.; Van Akkooi, Alexander C. J.; Schumacher, Ton N. Nature Medicine 2018
14676 10.1038/s41591-019-0357-y A Single Dose Of Neoadjuvant Pd-1 Blockade Predicts Clinical Outcomes In Resectable Melanoma Nature Medicine 2019
14684 10.1038/s41591-019-0448-9 Dabrafenib, Trametinib And Pembrolizumab Or Placebo In Braf-Mutant Melanoma Ascierto, Paolo Antonio, 0000-0002-8322-475X; Ferrucci, Pier Francesco; Fisher, Rosalie; Del Vecchio, Michele; Atkinson, Victoria; Schmidt, Henrik; Schachter, Jacob; Queirolo, Paola; Long, Georgina V., 0000-0001-8894-3545; Di Giacomo, Anna Maria; Svane, Inge Marie; Lotem, Michal; Bar-Sela, Gil; Couture, Felix; Mookerjee, Bijoyesh; Ghori, Razi; Ibrahim, Nageatte; Moreno, Blanca Homet; Ribas, Antoni, 0000-0003-3669-8458 Nature Medicine 2019
14686 10.1038/s41591-019-0474-7 Atezolizumab Plus Cobimetinib And Vemurafenib In Braf-Mutated Melanoma Patients Sullivan, Ryan J., 0000-0001-5344-6645; Hamid, Omid; Gonzalez, Rene; Infante, Jeffrey R.; Patel, Manish R.; Hodi, F. Stephen; Lewis, Karl D.; Tawbi, Hussein A.; Hernandez, Genevive; Wongchenko, Matthew J., 0000-0003-1230-7117; Chang, Yimeng; Roberts, Louise; Ballinger, Marcus; Yan, Yibing; Cha, Edward; Hwu, Patrick Nature Medicine 2019
14687 10.1038/s41591-019-0476-5 Combined Braf And Mek Inhibition With Pd-1 Blockade Immunotherapy In Braf-Mutant Melanoma Ribas, Antoni, 0000-0003-3669-8458; Lawrence, Donald; Atkinson, Victoria; Agarwal, Sachin; Miller, Wilson H.; Carlino, Matteo S.; Fisher, Rosalie; Long, Georgina V., 0000-0001-8894-3545; Hodi, F. Stephen; Tsoi, Jennifer; Grasso, Catherine S.; Mookerjee, Bijoyesh; Zhao, Qing; Ghori, Razi; Moreno, Blanca Homet; Ibrahim, Nageatte; Hamid, Omid Nature Medicine 2019
16056 10.1056/nejmoa1802357 Adjuvant Pembrolizumab Versus Placebo In Resected Stage Iii Melanoma Eggermont, Alexander M.M.; Blank, Christian U.; Mandala, Mario; Long, Georgina V., 0000-0001-8894-3545; Atkinson, Victoria; Dalle, Stephane; Haydon, Andrew; Lichinitser, Mikhail; Khattak, Adnan; Carlino, Matteo S.; Sandhu, Shahneen; Larkin, James; Puig, Susana; Ascierto, Paolo A.; Rutkowski, Piotr; Schadendorf, Dirk; Koornstra, Rutger; Hernandez-Aya, Leonel; Maio, Michele; Van Den Eertwegh, Alfonsus J.M.; Grob, Jean-Jacques; Gutzmer, Ralf; Jamal, Rahima; Lorigan, Paul; Ibrahim, Nageatte; Marreaud, Sandrine; Van Akkooi, Alexander C.J.; Suciu, Stefan; Robert, Caroline New England Journal Of Medicine 2018
16116 10.1056/nejmoa1904059 Five-Year Outcomes With Dabrafenib Plus Trametinib In Metastatic Melanoma Robert, Caroline; Grob, Jean J.; Stroyakovskiy, Daniil; Karaszewska, Boguslawa; Hauschild, Axel; Levchenko, Evgeny; Chiarion Sileni, Vanna; Schachter, Jacob; Garbe, Claus; Bondarenko, Igor; Gogas, Helen; Mandala, Mario; Haanen, John B.A.G.; Lebbe, Celeste; Mackiewicz, Andrzej; Rutkowski, Piotr; Nathan, Paul D.; Ribas, Antoni; Davies, Michael A.; Flaherty, Keith T.; Burgess, Paul; Tan, Monique; Gasal, Eduard; Voi, Maurizio; Schadendorf, Dirk; Long, Georgina V. New England Journal Of Medicine 2019
16136 10.1056/nejmoa1910836 Five-Year Survival With Combined Nivolumab And Ipilimumab In Advanced Melanoma Larkin, James; Chiarion-Sileni, Vanna; Gonzalez, Rene; Grob, Jean-Jacques; Rutkowski, Piotr; Lao, Christopher D.; Cowey, C. Lance; Schadendorf, Dirk; Wagstaff, John; Dummer, Reinhard; Ferrucci, Pier F.; Smylie, Michael; Hogg, David; Hill, Andrew; Marquez-Rodas, Ivan; Haanen, John; Guidoboni, Massimo; Maio, Michele; Schoffski, Patrick; Carlino, Matteo S.; Lebbe, Celeste; Mcarthur, Grant; Ascierto, Paolo A.; Daniels, Gregory A.; Long, Georgina V., 0000-0001-8894-3545; Bastholt, Lars; Rizzo, Jasmine I.; Balogh, Agnes; Moshyk, Andriy; Hodi, F. Stephen; Wolchok, Jedd D. New England Journal Of Medicine 2019
16175 10.1056/nejmoa2005493 Five-Year Analysis Of Adjuvant Dabrafenib Plus Trametinib In Stage Iii Melanoma Dummer, Reinhard; Hauschild, Axel; Santinami, Mario; Atkinson, Victoria; Mandala, Mario; Kirkwood, John M.; Chiarion Sileni, Vanna; Larkin, James; Nyakas, Marta; Dutriaux, Caroline; Haydon, Andrew; Robert, Caroline; Mortier, Laurent; Schachter, Jacob; Lesimple, Thierry; Plummer, Ruth; Dasgupta, Kohinoor; Gasal, Eduard; Tan, Monique; Long, Georgina V.; Schadendorf, Dirk, 0000-0003-3524-7858 New England Journal Of Medicine 2020
16972 10.1093/annonc/mdz011 Five-Year Survival Outcomes For Patients With Advanced Melanoma Treated With Pembrolizumab In Keynote-001 Hamid, O.; Robert, C.; Daud, A.; Hodi, F.S.; Hwu, W.J.; Kefford, R.; Wolchok, J.D.; Hersey, P.; Joseph, R.; Weber, J.S.; Dronca, R.; Mitchell, T.C.; Patnaik, A.; Zarour, H.M.; Joshua, A.M.; Zhao, Q.; Jensen, E.; Ahsan, S.; Ibrahim, N.; Ribas, A. Annals Of Oncology 2019
16978 10.1093/annonc/mdz110 Discontinuation Of Anti-Pd-1 Antibody Therapy In The Absence Of Disease Progression Or Treatment Limiting Toxicity: Clinical Outcomes In Advanced Melanoma Jansen, Y.J.L.; Rozeman, E.A.; Mason, R., 0000-0001-8055-9936; Goldinger, S.M.; Geukes Foppen, M.H.; Hoejberg, L.; Schmidt, H.; Van Thienen, J.V.; Haanen, J.B.A.G.; Tiainen, L.; Svane, I.M.; Makela, S.; Seremet, T.; Arance, A.; Dummer, R.; Bastholt, L.; Nyakas, M.; Straume, O.; Menzies, A.M.; Long, G.V.; Atkinson, V.; Blank, C.U.; Neyns, B. Annals Of Oncology 2019
20193 10.1186/s40425-019-0579-z Real-World Efficacy And Safety Of Nivolumab In Previously-Treated Metastatic Renal Cell Carcinoma, And Association Between Immune-Related Adverse Events And Survival: The Italian Expanded Access Program Verzoni, Elena; Carteni, Giacomo; Cortesi, Enrico; Giannarelli, Diana; De Giglio, Andrea; Sabbatini, Roberto; Buti, Sebastiano; Rossetti, Sabrina; Cognetti, Francesco; Rastelli, Francesca; Sobrero, Alberto; Turci, Daniele; Sternberg, Cora N.; Porta, Camillo; Cappuzzo, Federico; Tortora, Giampaolo; Tassinari, Davide; Panni, Stefano; Pazzola, Antonio; Surico, Gianmarco; Raimondi, Alessandra; De Giorgi, Ugo; Procopio, Giuseppe Journal For Immunotherapy Of Cancer 2019
20223 10.1200/jco.18.01219 Longer Follow-Up Confirms Relapse-Free Survival Benefit With Adjuvant Dabrafenib Plus Trametinib In Patients With Resected Braf V600<U+2013>Mutant Stage Iii Melanoma Hauschild, Axel; Dummer, Reinhard; Schadendorf, Dirk; Santinami, Mario; Atkinson, Victoria; Mandala, Mario; Chiarion-Sileni, Vanna; Larkin, James; Nyakas, Marta; Dutriaux, Caroline; Haydon, Andrew; Robert, Caroline; Mortier, Laurent; Schachter, Jacob; Lesimple, Thierry; Plummer, Ruth; Dasgupta, Kohinoor; Haas, Tomas; Shilkrut, Mark; Gasal, Eduard; Kefford, Richard; Kirkwood, John M.; Long, Georgina V. Journal Of Clinical Oncology 2018
20246 10.1200/jco.19.00318 Analysis Of The Association Between Adverse Events And Outcome In Patients Receiving A Programmed Death Protein 1 Or Programmed Death Ligand 1 Antibody Maher, V. Ellen; Fernandes, Laura L.; Weinstock, Chana; Tang, Shenghui; Agarwal, Sundeep; Brave, Michael; Ning, Yang-Min; Singh, Harpreet; Suzman, Daniel; Xu, James; Goldberg, Kirsten B.; Sridhara, Rajeshwari; Ibrahim, Amna; Theoret, Marc; Beaver, Julia A.; Pazdur, Richard Journal Of Clinical Oncology 2019
20265 10.1200/jco.19.01464 Long-Term Outcomes And Responses To Retreatment In Patients With Melanoma Treated With Pd-1 Blockade Betof Warner, Allison; Palmer, Jessica S.; Shoushtari, Alexander N.; Goldman, Debra A.; Panageas, Katherine S.; Hayes, Sara A.; Bajwa, Raazi; Momtaz, Parisa; Callahan, Margaret K.; Wolchok, Jedd D.; Postow, Michael A.; Chapman, Paul B. Journal Of Clinical Oncology 2020
20301 10.1200/jco.20.02110 Longer Follow-Up Confirms Recurrence-Free Survival Benefit Of Adjuvant Pembrolizumab In High-Risk Stage Iii Melanoma: Updated Results From The Eortc 1325-Mg/Keynote-054 Trial Eggermont, Alexander M. M.; Blank, Christian U.; Mandala, Mario; Long, Georgina V., 0000-0001-8894-3545; Atkinson, Victoria G.; Dalle, Stephane; Haydon, Andrew M.; Meshcheryakov, Andrey, 0000-0002-6009-653X; Khattak, Adnan; Carlino, Matteo S.; Sandhu, Shahneen; Larkin, James, 0000-0001-5569-9523; Puig, Susana; Ascierto, Paolo A., 0000-0002-8322-475X; Rutkowski, Piotr; Schadendorf, Dirk, 0000-0003-3524-7858; Koornstra, Rutger; Hernandez-Aya, Leonel; Di Giacomo, Anna Maria; Van Den Eertwegh, Alfonsus J. M.; Grob, Jean-Jacques, 0000-0002-0667-153X; Gutzmer, Ralf, 0000-0001-7921-2820; Jamal, Rahima; Lorigan, Paul C., 0000-0002-8875-2164; Van Akkooi, Alexander C. J.; Krepler, Clemens; Ibrahim, Nageatte, 0000-0003-0794-949X; Marreaud, Sandrine; Kicinski, Michal; Suciu, Stefan, 0000-0003-3281-8256; Robert, Caroline, 0000-0002-9493-0238 Journal Of Clinical Oncology 2020
20304 10.1200/jco.2017.75.6270 Durable Complete Response After Discontinuation Of Pembrolizumab In Patients With Metastatic Melanoma Robert, Caroline; Ribas, Antoni; Hamid, Omid; Daud, Adil; Wolchok, Jedd D.; Joshua, Anthony M.; Hwu, Wen-Jen; Weber, Jeffrey S.; Gangadhar, Tara C.; Joseph, Richard W.; Dronca, Roxana; Patnaik, Amita; Zarour, Hassane; Kefford, Richard; Hersey, Peter; Zhang, Jin; Anderson, James; Diede, Scott J.; Ebbinghaus, Scot; Hodi, F. Stephen Journal Of Clinical Oncology 2018